The value of rapid testing in bloodstream infections: From blood culture to clinical insights
Friday, September 18 at 15:00 CEST / 14:00 BST / 09:00 EDT / 06:00 PDT
The value of rapid testing in bloodstream infections lies in its ability to provide timely identification of pathogens and associated antimicrobial resistance (AMR) markers. Such information may potentially support earlier and more informed clinical decision-making, antimicrobial stewardship efforts, and improved patient management.
In this SelectScience® webinar, held in partnership with QIAGEN, our experts will share their early experience with the QIAstat-Dx BCID Plus AMR Panels, highlighting the role and value of rapid testing in the context of bloodstream infections.
Case-based discussions will illustrate how rapid pathogen identification and AMR marker detection may contribute to the interpretation of blood culture results, support antimicrobial stewardship strategies, and guide treatment considerations, with a focus on their potential clinical impact. The session will conclude with a live question-and-answer discussion with the speakers.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers
Who should attend?
- Clinical microbiologists
- Laboratory managers/directors
- Infectious disease physicians
- Antimicrobial stewardship (AMS) teams
- ICU and critical care clinicians
- Emergency medicine physicians
What will this webinar cover?
- The real-world performance of the QIAstat-Dx BCID Plus AMR Panels compared with routine microbiology methods.
- Workflow considerations for incorporating syndromic testing of positive blood cultures into laboratory diagnostic pathways.
- Clinical cases in which rapid pathogen and antimicrobial resistance marker results helped patient-management decisions.
- Factors that may guide the use of syndromic blood culture identification testing in the context of suspected sepsis.